A STUDY TO EVALUATE THE SAFETY AND EFFECTIVENESS OF A NEW NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR (NNRTI), (+)-CALANOLIDE A, IN HIV-POSITIVE PATIENTS WHO HAVE NEVER RECEIVED ANTI-HIV TREATMENT: